LanzaTech Announces Progress on Strategic Actions to Sharpen Business Focus and Improve Cost Structure

Core Insights - LanzaTech is transitioning from an innovation hub to a profitable enterprise, aiming for approximately $30 million in annual cash operating expense reductions [1][4] - The company is focusing on globally deploying proven technology and pursuing high-impact commercial projects aligned with profitability [2][4] - A strategic spin-out of its synthetic biology platform, LanzaX, and evaluation of scale-up opportunities for LanzaTech Nutritional Protein (LNP) are part of this transition [2] Financial and Operational Updates - The fourth quarter and full-year 2024 earnings call has been rescheduled to March 31, 2025, to align with the filing of the Annual Report on Form 10-K [1][5] - The company is implementing measures to evaluate its global footprint, which may lead to a workforce reduction of approximately 10 to 15 percent [4] Project Developments - High-priority commercial projects include waste-based ethanol-to-Sustainable Aviation Fuel (SAF) facilities in the UK and EU, each with a capacity of 30 million gallons per year [3] - The LanzaTech and LanzaJet CirculAir™ solution will be utilized in these projects to create an efficient offering for the aviation industry [3]